Andrew B Singleton, PhD

• Genetics
• Genomics
• Neurodegeneration
• Neurogenetics

Andrew received his B.Sc. from the University of Sunderland, United Kingdom and his Ph.D. from the University of Newcastle upon Tyne, United Kingdom. After postdoctoral work at the Mayo Clinic, Andrew moved to the National Institute on Aging, where he became a senior investigator and later, laboratory chief. In 2016, he became an NIH Distinguished Investigator and, in 2020, Andrew became the acting director of the new Center for Alzheimer’s and Related Dementias. Andrew has published over 600 articles. His group works on the genetic basis of neurological disorders including Parkinson’s disease, Alzheimer’s disease, dystonia, ataxia, dementia with Lewy bodies, and amyotrophic lateral sclerosis. The goal of this research is to identify genetic variability that causes or contributes to disease and to use this knowledge to understand the molecular processes underlying disease. Andrew has received the Annemarie Opprecht Award for Parkinson’s disease research, the Jay van Andel Award for Outstanding Achievement in Parkinson’s Disease Research, the American Academy of Neurology Movement Disorders Award, the Robert A. Pritzker Prize for Leadership in Parkinson’s Disease, and an Honorary Doctorate from the University of Sunderland.